STAT Plus: Pharmalittle: Trump considers executive action to cut drug prices; feds ‘not done’ with generic price-fixing probe
Rise and shine, everyone, another busy day is on the way. We can tell because our short person has left a cloud of dust after hastily departing for the local schoolhouse for another day of enlightened learning. As for us, we are firing up the trusty coffee kettle and trying to get organized for another round of phone calls and the like. Perhaps you can relate. Meanwhile, we have also assembled a few items of interest to help you with your own hectic schedule. Hope you conquer the world today and drop us a line if something saucy occurs.
President Trump is considering executive action to cut drug prices ahead of the 2020 election and tries to rebut Democratic criticism that his policies have hurt U.S. health care, Bloomberg News reports. If he proceeds, Trump would force drug makers to accept lower payments from Medicare for treatments administered in physician offices. The rule would apply to certain drugs bought by the “Part B” section of Medicare, the program for the elderly and disabled.
Continue to STAT Plus to read the full story…
